Pure Global
NCT05375383

Microbial Colonization of Oral Probiotics

Assessment of Colonisation of Probiotic Bacterium Streptococcus Salivarius in the Oral Cavity
BLIS Technologies Limited·ClinicalTrials.gov·dietary supplementRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Microbial Colonization
Drug/Device/Intervention
Streptococcus salivarius K12 lozenge
Study type
Interventional
Intervention type
dietary supplement
Sponsor & location
Primary sponsor
BLIS Technologies Limited
Location
Dunedin, New Zealand
Timeline & enrollment
Phase
N/A
Start date
Jun 15, 2022
End date
Sep 15, 2022
Enrollment
60 participants
Primary outcome

Change in microbial colonization from baseline (Day 0) to 1 hour for S. salivarius K12 lozenges,Change in microbial colonization from baseline (Day 0) to 8 hours or S. salivarius K12 lozenges,Change in microbial colonization from baseline (Day 0) to 24 hours or S. salivarius K12 lozenges,Change in microbial colonization from baseline (Day 0) to 48 hours or S. salivarius K12 lozenges,in microbial colonization from baseline (Day 0) to 1 hour for S. salivarius K12 powder format,in microbial colonization from baseline (Day 0) to 8 hour for S. salivarius K12 powder format,in microbial colonization from baseline (Day 0) to 24 hours for S. salivarius K12 powder format,in microbial colonization from baseline (Day 0) to 48 hours for S. salivarius K12 powder format,Change in microbial colonization from baseline (Day 0) to 1 hour for S. salivarius M18 lozenges,Change in microbial colonization from baseline (Day 0) to 8 hours for S. salivarius M18 lozenges,Change in microbial colonization from baseline (Day 0) to 24 hours for S. salivarius M18 lozenges,Change in microbial colonization from baseline (Day 0) to 48 hours for S. salivarius M18 lozenges

Summary

The aim of this study is to evaluate the colonization efficacy of probiotic lozenges and
 powders containing specific prebiotics in healthy adults

ICD-10 classifications
Bacterial infection of unspecified siteOther bacterial infections of unspecified siteBacterial, viral and other infectious agentsCholeraOther specified bacterial intestinal infections
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05375383
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05375383 through Pure Global AI's free database. This phase not specified trial is sponsored by BLIS Technologies Limited and is currently Recruiting. The study focuses on Microbial Colonization. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.